Junfeng Chu
- Topics
- Lymphoma Diagnosis and Treatment (10 papers)Chronic Lymphocytic Leukemia Research (3 papers)CAR-T cell therapy research (3 papers)
- Cited by
- OncologyImmunologyCancer Research
- Journals
- SHILAP Revista de lepidopterologíaBloodScientific Reports
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Junfeng Chu
33 papers receiving 428 citations
Peers
Comparison fields: 5 of 80
- Oncology 214
- Immunology 155
- Molecular Biology 129
- Pulmonary and Respiratory Medicine 77
- Cancer Research 64
Countries citing papers authored by Junfeng Chu
This map shows the geographic impact of Junfeng Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfeng Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfeng Chu more than expected).
Fields of papers citing papers by Junfeng Chu
This network shows the impact of papers produced by Junfeng Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfeng Chu. The network helps show where Junfeng Chu may publish in the future.
Co-authorship network of co-authors of Junfeng Chu
This figure shows the co-authorship network connecting the top 25 collaborators of Junfeng Chu. A scholar is included among the top collaborators of Junfeng Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junfeng Chu. Junfeng Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 108 | |
| 6 | 52 | |
| 7 | Safety and Efficacy of Chemotherapy Combined with Anlotinib Plus Anlotinib Maintenance in Chinese Patients with Advanced/Metastatic Soft Tissue Sarcoma | 1 |
| 8 | 11 | |
| 9 | 18 | |
| 10 | 20 | |
| 11 | 40 | |
| 12 | 3 | |
| 13 | pH and redox dual-responsive copolymer micelles with surface charge reversal for co-delivery of all-trans-retinoic acid and paclitaxel for cancer combination chemotherapy | 2 |
| 14 | 4 | |
| 15 | 11 | |
| 16 | 52 | |
| 17 | 12 | |
| 18 | [A novel rat aplastic anemia model induced by 5-fluorouracil combined with busulfan]. | 1 |
| 19 | [Distribution of three STR loci in Jingpo ethnic group in Yunnan province]. | 1 |
| 20 | 6 |
About Junfeng Chu
Junfeng Chu is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 33 papers that have together received 432 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Oncology (214 citations), Immunology (155 citations) and Cancer Research (64 citations). Junfeng Chu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Zheng Yan, Shuang Zhao, Zhihua Yao, Shuna Yao, Yanyan Liu, Meimei Yan, Fengcai Gao, Yanyan Liu, Haiying Wang and Qilong Gao. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.